HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
BIOTRONIK: BIO-LIBRA Initial Interim Analysis Results Demonstrate Higher Probability of Ventricular Tachyarrhythmias or Mortality in Men than Women
BIOTRONIK reports the results presented today show significant differences in one-year ventricular tachyarrhythmia or death rates by sex in patients with non-ischemic cardiomyopathy with an ICD or CRT-D.
Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF
Zio The new clinical evidence further validates the Zio service as a viable solution for the early detection of atrial fibrillation (AF),1 helping undiagnosed populations effectively seek treatment before more serious problems can occur.
ACC.22: Medtronic Renal Denervation System Demonstrates Significant BP Reduction Through 3 Years
ACC.22: Medtronic adds to its robust clinical program with long-term data demonstrating the continued blood pressure lowering effect of the Symplicity renal denervation procedure. Also
completes enrollment in the SPYRAL HTN-ON MED trial.
Corvia Medical Reports: Reduce Lap-HF II Analyses Show 50% of Study Patients Demonstrated Significant Clinical Benefit from the Corvia Atrial Shunt
Corvia Medical notes in a large responder population, representing 50% of study patients, treatment with the Corvia® Atrial Shunt resulted in a 45% reduction in HF events and a 55% greater improvement in quality of life compared to sham control.
ReCor Medical Announces Completion of Enrollment in RADIANCE-II Pivotal Trial
ReCor Medical notes the data from RADIANCE-II will build on evidence from RADIANCE-HTN SOLO and TRIO studies to support pre-market application to the FDA
HeartPoint Global Implant System Proves Safety and Efficacy
HeartPoint Global notes this new milestone follows the company's successful exploration of the HeartPoint Global Implant System in the arterial branches.
SpineX Announces Successful 1st in Human Study Results of SCONE therapy to treat Urge Urinary Incontinence
SpineX notes SCONE™, a non-invasive transcutaneous spinal cord neuromodulator is the first of its kind device that is being developed to treat bladder dysfunction.
Hinge Health Reports: New Study Demonstrates that Hinge Health Delivers Sustained 1-year Improvement in Pain, Anxiety, Depression, and Function
Hinge Health said a joint study with researchers from UCSF and the University of Rhode Island is the first to demonstrate long-term outcomes of a digital musculoskeletal solution.
Type 1 Diabetes and AI: Harnessing the Power of AI to Advance Knowledge of Type 1 Diabetes
In the study, the team analyzed publicly available, real-world data from about 16,000 participants enrolled in the T1D Exchange Clinic Registry.